Genetic and other ancillary tests can be extremely useful resources for pathologists, clinicians, and patients. There are a wide variety of tests used in cancer diagnostics, prognostics, and theranostics. For…
Read More
Lumea, the leader in integrated digital pathology, & OptraSCAN, the top end-to-end digital pathology solution provider, announced a collaboration agreement. LEHI, UTAH, UNITED STATES, April 27, 2023 — Lumea, a…
Welcome to our first podcast episode, sponsored by the Digital Diagnostic Summit and Lumea! Today our guest pathologists Jonhan Ho, MD, and Swikrity U Baskota, MD, share their top three…
The Digital Diagnostic Summit and Lumea are pleased to announce the start of a new pathology podcast: Ask a Pathologist. This podcast is a place where experienced pathologists come together…
When you hear the term digital pathology technology, there’s a good chance that whole slide image scanners, image viewers, and LIS integrations come to mind. In addition, complexity, change management,…
Simple Summary The current need to reduce costs in research and diagnostic histopathology is fueling the development of new technologies. Tissue microarray (TMA) technology facilitates the simultaneous preparation of multiple…
